Vanguard Asset Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Vanguard Asset Management's ADMA Position: Q3 2026 in Review
Vanguard Asset Management increased its ADMA Biologics (ADMA) stake by 11% in Q3 2026, buying an estimated $209K and bringing the position to 228,653 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1488.
Vanguard Asset Management first reported a position in ADMA in Q1 2026 and has held it in 3 quarters since. 329 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- Vanguard Asset Management held 228,653 shares of ADMA Biologics worth $2.29M as of Q3 2026.
- Vanguard Asset Management bought 22,634 ADMA Biologics shares in Q3 2026, an estimated $209K.
- ADMA Biologics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1488 holding.
- Vanguard Asset Management first reported a position in ADMA Biologics in Q1 2026 and has held it in 3 quarters since.
- 329 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.